XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Investments:    
Fixed maturity securities, available for sale, at fair value (amortized cost of $37,813,550 as of 2023 and $44,866,019 as of 2022; allowance for credit losses of $3,618 as of 2023 and $3,347 as of 2022) $ 32,084,932 $ 39,804,617 [1]
Mortgage loans, carrying value 7,494,983 6,949,027 [1]
Limited partnerships and limited liability companies (2023 and 2022 include $1,172,525 and $684,834 related to consolidated variable interest entities) 1,763,551 1,266,779 [1]
Derivative instruments 733,784 431,727 [1]
Other investments 1,207,672 1,817,085 [1]
Total investments 44,587,107 51,325,298 [1]
Cash and cash equivalents (2023 and 2022 include $41,982 and $27,235 related to consolidated variable interest entities) 10,188,438 1,919,669 [1]
Coinsurance deposits (net of allowance for credit losses of $5,490 as of 2023 and $8,737 as of 2022) 14,628,884 13,254,956 [1]
Market risk benefits 346,515 229,871 [1]
Accrued investment income (2023 and 2022 include $2,658 and $3,444 related to consolidated variable interest entities) 443,642 497,851 [1]
Deferred policy acquisition costs 2,933,304 2,773,643 [1]
Deferred sales inducements 2,257,064 2,045,683 [1]
Deferred income taxes 425,398 438,434 [1]
Income taxes recoverable 55,498 55,498 [1]
Other assets (2023 and 2022 include $17,426 and $10,690 related to consolidated variable interest entities) 847,047 642,696 [1]
Total assets 76,712,897 73,183,599 [1]
Liabilities:    
Policy benefit reserves 60,226,094 58,781,836 [1]
Market risk benefits 2,552,907 2,455,492 [1]
Other policy funds and contract claims 196,299 512,790 [1]
Notes and loan payable 787,098 792,073 [1]
Subordinated debentures 79,017 78,753 [1]
Funds withheld for reinsurance liabilities 8,139,724 6,577,426 [1]
Other liabilities (2023 and 2022 include $91,734 and $78,644 related to consolidated variable interest entities) 2,655,213 1,614,479 [1]
Total liabilities 74,636,352 70,812,849 [1]
Stockholders' equity:    
Common stock; par value $1 per share; 200,000,000 shares authorized; issued and outstanding: 2023 - 78,974,095 shares (excluding 30,971,013 treasury shares); 2022 - 84,810,255 shares (excluding 24,590,353 treasury shares) 78,974 84,810 [1]
Additional paid-in capital 1,071,907 1,325,316 [1]
Accumulated other comprehensive loss (4,425,695) (3,746,230) [1]
Retained earnings 5,328,362 4,685,593 [1]
Total stockholders' equity attributable to American Equity Investment Life Holding Company 2,053,576 2,349,517 [1]
Noncontrolling interests 22,969 21,233 [1]
Total stockholders' equity 2,076,545 2,370,750 [1]
Total liabilities and stockholders' equity 76,712,897 73,183,599 [1]
Depositary Shares, each representing a 1/1,000th interest in a share of 5.95% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series A    
Stockholders' equity:    
Preferred stock 16 16 [1]
Depositary Shares, each representing a 1/1,000th interest in a share of 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B    
Stockholders' equity:    
Preferred stock 12 12 [1]
Variable Interest Entities    
Investments:    
Real estate investments related to consolidated variable interest entities 1,302,185 1,056,063 [1]
Limited partnerships and limited liability companies (2023 and 2022 include $1,172,525 and $684,834 related to consolidated variable interest entities) 1,172,525 684,834
Cash and cash equivalents (2023 and 2022 include $41,982 and $27,235 related to consolidated variable interest entities) 41,982 27,235
Accrued investment income (2023 and 2022 include $2,658 and $3,444 related to consolidated variable interest entities) 2,658 3,444
Other assets (2023 and 2022 include $17,426 and $10,690 related to consolidated variable interest entities) 17,426 10,690
Total assets 2,536,776 1,782,266
Liabilities:    
Other liabilities (2023 and 2022 include $91,734 and $78,644 related to consolidated variable interest entities) 91,734 78,644
Total liabilities $ 91,734 $ 78,644
[1] Certain prior period amounts have been recast. See Note 1 - Significant Accounting Policies for more information.